镰状细胞病中的肾脏异常
Renal abnormalities in sickle cell disease.
作者信息
Ataga K I, Orringer E P
机构信息
Division of Hematology/Oncology, Department of Medicine, UNC Comprehensive Sickle Cell Program & General Clinical Research Center, University of North Carolina, Chapel Hill, North Carolina, USA.
出版信息
Am J Hematol. 2000 Apr;63(4):205-11. doi: 10.1002/(sici)1096-8652(200004)63:4<205::aid-ajh8>3.0.co;2-8.
Sickle cell anemia and the related hemoglobinopathies are associated with a large spectrum of renal abnormalities. The patients have impaired urinary concentrating ability, defects in urinary acidification and potassium excretion, and supranormal proximal tubular function. The latter is manifest by increased secretion of creatinine and by reabsorption of phosphorus and beta(2)-microglobulin. Young patients with sickle cell disease (SCD) have supranormal renal hemodynamics with elevations in both effective renal plasma flow (ERPF) and glomerular filtration rate (GFR). These parameters decrease with age as well as following the administration of prostaglandin inhibitors. Proteinuria, a common finding in adults with sickle cell disease, may progress to the nephrotic syndrome. Proteinuria, hypertension, and increasing anemia predict end-stage renal disease (ESRD). While ESRD can be managed by dialysis and/or renal transplantation, there may be an increased rate of complications in renal transplant recipients with SCD. Hematuria is seen in individuals with all of the SCDs as well as with sickle cell trait. In most cases the etiology of the hematuria turns out to be benign. However, there does appear to be an increased association between SCD and renal medullary carcinoma. Therefore, those SCD patients who present with hematuria should initially undergo a thorough evaluation in order to exclude this aggressive neoplasm. Papillary necrosis may occur due to medullary ischemia and infarction. Erythropoietin levels are usually lower than expected for their degree of anemia and decrease further as renal function deteriorates. An abnormal balance of renal prostaglandins may be responsible for some of the changes in sickle cell nephropathy. Acute renal failure is a component of the acute multiorgan failure syndrome (MOFS). Finally, progression of sickle cell nephropathy to ESRD may be slowed by adequate control of hypertension and proteinuria. However, the prevention of the renal complications of SCD will require a cure for this genetic disorder.
镰状细胞贫血及相关血红蛋白病与一系列肾脏异常有关。患者的尿液浓缩能力受损,尿液酸化及钾排泄存在缺陷,近端肾小管功能超常。后者表现为肌酐分泌增加以及磷和β2-微球蛋白重吸收增加。患有镰状细胞病(SCD)的年轻患者肾脏血流动力学超常,有效肾血浆流量(ERPF)和肾小球滤过率(GFR)均升高。随着年龄增长以及使用前列腺素抑制剂后,这些参数会降低。蛋白尿是成年镰状细胞病患者的常见表现,可能会发展为肾病综合征。蛋白尿、高血压和贫血加重预示着终末期肾病(ESRD)。虽然ESRD可通过透析和/或肾移植进行治疗,但SCD肾移植受者的并发症发生率可能会增加。血尿见于所有类型的SCD患者以及镰状细胞性状个体。在大多数情况下,血尿的病因是良性的。然而,SCD与肾髓质癌之间的关联似乎确实增加。因此,出现血尿的SCD患者应首先进行全面评估,以排除这种侵袭性肿瘤。由于髓质缺血和梗死可能会发生乳头坏死。促红细胞生成素水平通常低于与其贫血程度预期的值,并且随着肾功能恶化而进一步降低。肾前列腺素的异常平衡可能是镰状细胞肾病某些变化的原因。急性肾衰竭是急性多器官功能衰竭综合征(MOFS)的一部分。最后,通过充分控制高血压和蛋白尿,可减缓镰状细胞肾病向ESRD的进展。然而,要预防SCD的肾脏并发症需要治愈这种遗传性疾病。